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Introduction
The incidence of fungal infections is 
increasing at an alarming rate, presenting an 
enormous challenge to healthcare 
professionals. This increase is directly related 
to the growing population of 
immunocompromised individuals, resulting 
from changes in medical practice such as the 
use of intensive chemotherapy and 
immunosuppressive drugs.1 The most 
common fungal infections of humans are 
caused by the Candida, Cryptococcus and 
Aspergillus species.2,3 In addition, gains in 
many areas of these disease controls are 
seriously jeopardized by the emergence of 
drug-resistant clinical isolates to the available 
drugs.4 Treatment of deeply invasive 
infections has consistently lagged behind 
chemotherapy; new approaches are urgently 
needed for improved diagnosis, including 
species identification, rapid and predictive 
susceptibility assays, and effective treatment5. 
In view of the above and as part of the our 
ongoing research on electron rich nitrogen 
heterocycle system comprises 1,3,5-triazine 
antimicrobials, which is 5-aza-bioisoster of 
purine is an important pharmacophore and 
privileged structure in medicinal chemistry,
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has been shown to be a favorable scaffold for 
the design of biologically active antimicrobial 
compounds, including antibacterial,6
antimalarial,7 antiviral8 and anticancer 
agents.9 However, data concerning antifungal 
activities of these compounds are very 
limited.10 The continuous demand to develop 
efficient synthetic methods has prompted the 
researchers to use 1,3,5-triazine as a cheap 
reactive for many group transformations.11
Thiazole is another considerable 
pharmacophore group and has been reported 
to exhibit a variety of biological activities
including antibacterial and antifungal
anthelmintic.12 On the basis of immense 
pharmacological action triazine and thiazole, 
it is noteworthy to synthesize these leads by 
clubbing together and to screen them for 
potential antifungal activity.
Furthermore, after extensive literature
search, it was observed that, till date enough
efforts have not been made to combine these
two vital moieties as a single molecular
scaffold and to study its antifungal activity. In 
our earlier work, we have developed some 
amino triazine derivatives bearing thiazole 
pendant, via nucleophilic substitution reaction 
of 1,3,5-triazine with various aromatic and 
substituted phenyl thiazole amines, as a novel 
potent antibacterial agent.13,14,15  Prompted by 
these reports, and continuing to our interest in 
exploration of chemical and biological 
activities of 1,3,5-triazine derivatives, we 
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2herein, report in-vitro antifungal activities of 
these constitutive compounds, against few 
fungal species viz. Candida, Cryptococcus
and Aspergillus.
Results and discussion
As depicted from table 1, compounds exhibits 
numerous degree of inhibition pattern on 
tested fungal species. Among the synthesized 
compound (1-6), moderate to no activity was 
observed with halogen substituted aromatic 
amines fragments along with substituted 
phenyl thiazole amines. Out of which, 
molecule having di-(4-chloro phenyl amine)
with 4-nitro phenyl thiazole amine side chains 
(3), posses no activity against fungal species. 
Significant activity was achieved in case of 
analogue having di-halogen phenyl amine 
fragment 1 and 2 (3-chloro,4-phenyl amine). 
And further 4-chloro phenyl thiazole amine 1
was found more active (MFC=2.50 for A. 
niger equivalent to fluconazole) than their 
corresponding 4-nitro phenyl thiazole amine 
derivative 2. Compound 6, posses no activity 
against all tested microorganism although it 
contain 4-nitro phenyl thiazole amine side 
chain.
These finding indicates that, presence 
of hydrophobic fragments and electron 
withdrawing groups could modulate the 
antifungal activity of test compounds. The
reason for this result may be explained by
electron density of the compounds. It has
been reported that electron-donating groups
increase the electron density which makes the
compounds effective against microorganisms 
and enhances the antibacterial activity.16
However, high electron density causes more
difficult diffusion through the fungal cell and
substantial activity loss may occur.17 Thus,
for a compound an optimum electron density
is inevitable so as to gain a significant 
antibacterial activity.
Conclusion
During the course of study, varyingly 
substituted 1,3,5-triazines were screened for 
their antifungal activity. It obvious from 
Structure Activity Profile that, antifungal 
activity of these tri-substituted triazines is 
associated with their individual triazine 
nucleus as well as the phenyl thiazole motifs 
in their hybrid skeletons. 
In the light of above said we can say 
that for effective triazine antifungal agent, it 
should have di hydrophobic fragment with 
electron withdrawing atom on phenyl of 
thiazole side chain and showed the 
importance of electronic environment on 
antimicrobial activity.
Findings from the SAR studies have
encouraged us to make some modifications on
basic skeleton of the obtained leads to achieve
efficacious and potent and derivatives in 
ongoing studies. In addition, for further
investigations these findings can have a good
approach on scientists to synthesize similar 
analogues.
Experimental
Antifungal  activity
The synthesized compounds, tri-
substituted 1,3,5-triazine derivatives were 
screened for their antifungal activity (MIC 
and MFC) against four fungi viz. Candida 
species (C. albicans NCIM-3102, C. glabrata 
NCIM-3266), Cryptococcus neoformans 
NCIM-3542, and Aspergillus niger NCIM-
620 using modified broth microdilution 
method recommended by CLSI,18,19 using 
fungistatic fluconazole and fungicidal 
amphotericin B as standard controls. The 
Candida spp. and C. neoformans strains were 
subculture on sabouraud dextrose agar at 
35oC±1°C for 24 h and 48 h respectively, 
while A. niger strains were subcultured 
35oC±1°C for 4 days. 
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suspensions were diluted with modified broth, 
RPMI 1640 medium at pH 4.5 in comparison 
to 0.5 McFarland standard to afford final 
target inocula of 5.0×103 and 5.0×105 for 
Candida spp. and C. neoformans respectively 
and A. niger inoculum was made to 4.0×104 
colony forming units (CFU)/ml at pH 7.3 with 
the same RPMI 1640 medium in 5% Alamar 
blue. The fungal inocula were added to the 
samples to achieve a final volume of 200 µL. 
Eight serial dilutions, starting with 20.0000
µg/ml of the compounds (dissolved in 
dimethyl sulfoxide, DMSO) were made using 
20% dimethyl sulfoxide in normal saline to 
afford least concentration of 0.1563 µg/ml
(=0.16 µg/ml) and transferred in duplicate to 
96-well flat-bottom microplates. All 
organisms were examined at 630 nm prior to 
and after incubation (Candida spp. at 
37°C±1°C, 18 to 24 h; while for C. 
neoformans and A. niger at 35°C±1°C, 72 h). 
The lowest test concentration that allowed no 
detectable growth (or no more than 20% 
growth for Fluconazole, for A. niger, no color 
change from blue to pink) was defined as the 
minimum inhibitory concentration (MIC).
Minimum fungicidal concentrations (MFCs) 
were determined by removing 5 µl from each 
clear (or blue) well, transferring to relevant 
agar, and incubating as previously mentioned. 
The MFC was defined as the lowest test 
concentration that allows no growth of the 
organism on agar.
Table 2: In-vitro antifungal activity (MIC/MFC µg/ml) of tri-substituted-1,3,5-triazine 
derivatives. 
C. albicans C.glabrata C. neoformans A. niger
Compound
Structure MIC MFC MIC MFC MIC MFC MIC MFC
1 N
N
N
N
H
HN
NH
S
N
Cl
Cl
F
Cl
F
1.25 5.00 2.50 5.00 5.00 20.00 2.50 2.50
2 N
N
N
N
H
HN
NH
S
N
NO2
Cl
F
Cl
F
2.50 10.00 5.00 - 2.50 10.00 5.00 -
3
N
N
N
N
H
HN
NH
S
N
NO2
NO2O2N
5.00 - 10.00 - 2.50 - 5.00 10.00
4
N
N
N
N
H
HN
NH
S
N
NO2
FF
10.00 - 5.00 - - - - -
5
N
N
N
N
H
HN
NH
S
N
NO2
ClCl
- - 5.00 - - - 5.00 10.00
6
N
N
N
N
H
HN
NH
S
N
NO2
BrBr
10.00 20.00 10.00 10.00 - - 5.00 20.00
Fluconazole 0.63 - 0.63 - - - - -
Amphotericin B 0.16 0.63 0.32 0.63 1.25 1.25 0.63 2.50
- Not active at the highest test concentration of 20 µg/ml.
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